PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PET imaging reveals long-term heart and lung damage from COVID-19

New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

Thumbnail

Imaging shows why music makes us happy

Experts believe their findings could be significant for treating both pain and mental health disorders. 

PET method offers new insight into inflammation of the brain

Researchers are hopeful that their technique could improve the diagnosis of conditions associated with neural inflammation. 

Thumbnail

New PET imaging method could improve our understanding of long COVID

Researchers have developed a new radiotracer that targets one of the virus’ spike proteins, allowing them to track it longitudinally.  

FDA approves new prostate cancer imaging agent with extended shelf life

The new product from Telix paves the way for increased access at clinics where prostate PET may not have been available in the past.

Researchers track dopamine receptors to study its impact on cognitive function.

New PET study offers insight into how dopamine drives executive function

These findings could help guide the development of new treatments for psychiatric and neurological disorders.  

HeartSee 4.0 Bracco Diagnostics

Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

lung cancer screening

New PET method combines antibody with radioactive isotope to improve lung cancer detection

By giving providers greater insight into a tumor’s molecular footprint, the method could also reduce the need for invasive biopsies.